Literature DB >> 25421652

Cancer epigenetics: an introduction.

Rajnee Kanwal1, Karishma Gupta, Sanjay Gupta.   

Abstract

Epigenetic and genetic alterations contribute to cancer initiation and progression. Epigenetics refers to the study of heritable changes in gene expression without alterations in DNA sequences. Epigenetic changes are reversible and include key processes of DNA methylation, chromatin modifications, nucleosome positioning, and alterations in noncoding RNA profiles. Disruptions in epigenetic processes can lead to altered gene function and cellular neoplastic transformation. Epigenetic modifications precede genetic changes and usually occur at an early stage in neoplastic development. Recent technological advances offer a better understanding of the underlying epigenetic alterations during carcinogenesis and provide insight into the discovery of putative epigenetic biomarkers for detection, prognosis, risk assessment, and disease monitoring. In this chapter we provide information on various epigenetic mechanisms and their role in carcinogenesis, in particular, epigenetic modifications causing genetic changes and the potential clinical impact of epigenetic research in the future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25421652     DOI: 10.1007/978-1-4939-1804-1_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  62 in total

Review 1.  Genomic Subtyping in Bladder Cancer.

Authors:  Tuomas Jalanko; Joep J de Jong; Ewan A Gibb; Roland Seiler; Peter C Black
Journal:  Curr Urol Rep       Date:  2020-03-13       Impact factor: 3.092

Review 2.  Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation.

Authors:  Micah G Donovan; Spencer N Wren; Mikia Cenker; Ornella I Selmin; Donato F Romagnolo
Journal:  Br J Pharmacol       Date:  2020-01-26       Impact factor: 8.739

3.  ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases.

Authors:  Verena Kirn; Leonie Strake; Fabinshy Thangarajah; Lisa Richters; Hannah Eischeid; Ulrike Koitzsch; Margarete Odenthal; Jochen Fries
Journal:  Clin Exp Metastasis       Date:  2018-09-01       Impact factor: 5.150

4.  DNA methylation in promoter regions of genes involved in the reproductive and metabolic function of children born to women with PCOS.

Authors:  Bárbara Echiburú; Fermín Milagro; Nicolás Crisosto; Francisco Pérez-Bravo; Cristian Flores; Ana Arpón; Francisca Salas-Pérez; Sergio E Recabarren; Teresa Sir-Petermann; Manuel Maliqueo
Journal:  Epigenetics       Date:  2020-04-20       Impact factor: 4.528

5.  Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.

Authors:  Dhruvajyoti Roy; Maarit Tiirikainen
Journal:  Trends Cancer       Date:  2020-02-03

6.  AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma.

Authors:  J Jiao; Y Jin; M Zheng; H Zhang; M Yuan; Z Lv; W Odhiambo; X Yu; P Zhang; C Li; Y Ma; Y Ji
Journal:  Clin Exp Immunol       Date:  2018-11-13       Impact factor: 4.330

Review 7.  Epigenetic mechanisms of tumor resistance to immunotherapy.

Authors:  Natalia Arenas-Ramirez; Dilara Sahin; Onur Boyman
Journal:  Cell Mol Life Sci       Date:  2018-08-23       Impact factor: 9.261

Review 8.  Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation.

Authors:  Kristen M Humphrey; Sumali Pandey; Jeffery Martin; Tamara Hagoel; Anne Grand'Maison; Joyce E Ohm
Journal:  Semin Cancer Biol       Date:  2018-11-16       Impact factor: 15.707

9.  TIP60/P400/H4K12ac Plays a Role as a Heterochromatin Back-up Skeleton in Breast Cancer.

Authors:  Mouhamed Idrissou; Tiphanie Boisnier; Anna Sanchez; Fatma Zohra Houfaf Khoufaf; Frederique Penault-Llorca; Yves-Jean Bignon; Dominique Bernard-Gallon
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

10.  JMJD5 is a potential oncogene for colon carcinogenesis.

Authors:  Ru Zhang; Qingjun Huang; Yinpeng Li; Yang Song; Yingxue Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.